CMS Scraps ‘Most Favored Nation’ Rule To Lower Medicare Part B Drug Costs

US Centers For Medicare and Medicaid Services doesn’t tip its hand on what, if anything, might replace the rule but says it is exploring ways to lower spending on Medicare Part B drugs.

Infusion of a hospital
Trump-Era Plan To Lower Cost Of Physician Administered Drugs Scuttled

The US Centers for Medicare and Medicaid Services aims to withdraw the Trump administration's plan for a demonstration project to lower Medicare spending on high-cost Part B drugs by matching reimbursement rates to the lowest price found in certain countries abroad, also known as the "most favored nation" policy. 

The move comes less than a month before the Biden administration is slated to outline some of its own drug...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access